Posted on 8/24/20
Better Coronavirus Stock: CureVac vs. Moderna
U.S. investors' enthusiasm over Moderna (NASDAQ:MRNA) began earlier this year after the biotech launched its effort to develop a novel coronavirus vaccine. CureVac (NASDAQ:CVAC) hasn't generated . . .
Posted on 8/23/20
Kymera Therapeutics Prices Upsized IPO
WATERTOWN, Mass., Aug. 20, 2020 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that . . .
Posted on 8/23/20
Yield10 Bioscience Prices $5.2M Public Offering and Concurrent Private Placement
WOBURN, Mass., Aug. 22, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced the pricing of its underwritten public offering . . .
Posted on 8/23/20
Yield10 Bioscience Proposes Public Offering of Common Stock
WOBURN, Mass., Aug. 21, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced it has commenced an underwritten public offering . . .
Posted on 8/20/20
The Greeley Company Announces Medical Staff Services Partnership with Huntington Hospital
The Greeley Company, a division of The Chartis Group and a leader in healthcare consulting, education, external peer review and interim staffing solutions, announces a new . . .
Posted on 8/20/20
Alzheon Awarded $47 Million Grant from U.S. National Institute
FRAMINGHAM, Mass.--(BUSINESS WIRE)--Alzheon, Inc., a clinical-stage biopharmaceutical company focused on developing new medicines for patients suffering from Alzheimer’s disease (AD) and other neurodegenerative disorders, announced today . . .
Posted on 8/19/20
J&J To Acquire Momenta Pharmaceuticals For $6.5B
Johnson & Johnson (NYSE:JNJ) has agreed to acquire Momenta Pharmaceuticals (NASDAQ:MNTA) for $52.50 per share in cash for a total of $6.5B.
Posted on 8/18/20
Keystone Dental Group and Digital Dentistry Institute Announce Strategic Partnership
Keystone Dental Group (KDG) and Digital Dentistry Institute (DDI) are pleased to announce they have entered a partnership, combining KDG, a pioneer in science-based surgical and . . .
Posted on 8/18/20
PatientPing and HAPevolve Partner
PatientPing today announced an endorsed partnership with HAPevolve, a subsidiary company of The Hospital and Healthsystem Association of Pennsylvania (HAP), to streamline care and improve patient . . .
Posted on 8/18/20
Therapure Biomanufacturing Signs Manufacturing Deal With VBI Vaccines
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Therapure Biomanufacturing, a division of Therapure Biopharma Inc., announced today the signing of an agreement with VBI Vaccines Inc. for the manufacture of their . . .
Posted on 8/18/20
IPO Update: Kymera Therapeutics Readies $125 Million IPO
SummaryKymera Therapeutics has filed proposed terms for its U.S. IPO.The firm is developing treatments for various skin and immune system conditions.KYMR is still at a preclinical . . .
Posted on 8/17/20
Seres Therapeutics Closes Public Offerings of 12,075,000 Shares of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics platform company developing a novel class of multifunctional bacterial consortia that are designed to functionally . . .
Posted on 8/17/20
Gilead Sciences and Tango Therapeutics to Expand Strategic Oncology Collaboration
FOSTER CITY, Calif. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) and Tango Therapeutics today announced an expanded strategic collaboration focused on the discovery, development and . . .
Posted on 8/17/20
Dragonfly Therapeutics and Bristol Myers Squibb Announce Exclusive Global License
NEW YORK & WALTHAM, Mass.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) and Dragonfly Therapeutics, Inc., today announced that they have entered into a definitive agreement under which . . .
Posted on 8/17/20
Blackstone and Alnylam Close $150 Million R&D Financing
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Blackstone (NYSE: BX) and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced the closing of the R&D funding component of . . .
Posted on 8/17/20
Moderna and Other Coronavirus Vaccine Makers to Take Reduced Payments If Approval Milestones Not Met
If Moderna (NASDAQ:MRNA) and its peers take too long to get their current coronavirus vaccine candidates fully developed and approved, they could pay the price. The . . .
Posted on 8/17/20
Is Cognex Stock a Buy?
Machine vision company Cognex Corporation (NASDAQ:CGNX) has had a difficult year, but somehow the stock is up nearly 17% at the time of writing. What's going . . .
Posted on 8/17/20
AGTC Formalizes Patient Advisory Council
GAINESVILLE, Fla., and CAMBRIDGE, Mass., (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company focused on developing adeno-associated virus (AAV) based gene therapies . . .
Posted on 8/17/20
Sarepta Therapeutics and University of Florida Announce Collaboration
CAMBRIDGE, Mass. and GAINESVILLE, Fla., (GLOBE NEWSWIRE) -- Sarepta Therapeutics Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, and the University of Florida . . .
Posted on 8/17/20
Black Diamond Therapeutics Provides Corporate Update
CAMBRIDGE, Mass. and NEW YORK (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of small . . .
Posted on 8/17/20
Interview with Babak Movassaghi, CEO at InfiniteMD
Telehealth is certainly a complex and evolving industry, especially over the past few months. Due to COVID-19, now more than ever, elite clinical teams are being sought . . .
Posted on 8/17/20
BioXcel Therapeutics Provides Business Update
NEW HAVEN, Conn., Aug. 14, 2020 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence to identify improved therapies in neuroscience . . .
Posted on 8/14/20
Imara Reports Second Quarter 2020 Financial Results and Business Highlights
BOSTON, Aug. 14, 2020 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering . . .
Posted on 8/14/20
Berkshire Hathaway Is Up 19% Quarter to Date: Here’s Why It’s Still Cheap
Don't look now, but after underperforming the stock market for the first half of 2020, Warren Buffett-led conglomerate Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) is up a whopping . . .
Posted on 8/14/20
Why Warren Buffett Might Not Be Crazy About Biopharma Stocks
Few investors would intentionally go against the judgment of the most famous -- and, arguably the most successful -- investor in history, but if you've ever . . .
Boston
